Efficacy results of our vaccine immunotherapy on a mCRC preclinical model
1st scientific show-up for Brenus Pharma in a top oncology congress !! “Efficacy results of a novel vaccine composed of stimulated and haptenized tumours cells in
Balbc mice grafted with murine colon adenocarcinoma CT26 cells” was presented during the AACR 21: Tumor Immunology and Immunotherapy congress !
AACR selected sciences in #cancerImmunology and #Immunotherapy to broaden our understanding of ways to harness the immune system to treat #cancer: We are porud to be part on this congress to present our #innovative discovery #Oncologyplateform !
Many thanks to all the authors who contributed to the success of this abstract and Dr.C CONGORA (PhD, head of preclinical study department at IRCM – Institut de Recherche en Cancérologie de Montpellier, for the great presentation
Stay tuned: the presentation will be available as you please till January!